Lintitript

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLintitript
Drug Alias Namelintitriptum林替曲特SR-27897
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholecystokinin A receptor antagonists
TargetsCholecystokinin A receptor
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksDrugBank